H. Cross John's Insider Trades & SAST Disclosures

H. Cross John's most recent trade in Sonnet BioTherapeutics Holdings Inc was a trade of 1,452 Common Stock done . Disclosure was reported to the exchange on Dec. 11, 2023.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Sonnet BioTherapeutics Hol...
H. Cross John Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Dec 2023 1,452 1,588 - - Common Stock
Sonnet BioTherapeutics Hol...
John H. Cross Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.06 per share. 06 Feb 2023 1,960 23,927 - 1.1 2,078 Common Stock
Sonnet BioTherapeutics Hol...
John H. Cross Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Dec 2022 15,519 160,684 - - Common Stock
Sonnet BioTherapeutics Hol...
John H. Cross Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jul 2020 78,214 78,214 - 0 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades